Home
About
Product
magNews
Career
Contact Us
中文
English
Search News
Corporate
Industry
Technology
Medical Updates
Heart transplant
Corporate
magAssist Attains Recognition as the Most Innovative Medical Device Product of 2023
2023-08-21
Corporate
MoyoAssist® Extra-VAD, a Promising Solution for Short-to-Medium-Term Ventricular Assist for China NMPA trial, Showcased at 4th Academic Annual Conference of CSBE
2023-06-17
Corporate
magAssist Revealed in MedTech Outlook's Top 10 MedTech Companies in APAC Region for 2022
2023-03-14
Corporate
magAssist Gains Recognition for Its Innovation in the Cardiovascular Field at 2022 Critical Heart Disease Congress-International Society for Mechanical Circulatory Support Parallel Forum
2023-01-16
Technology
Professor Nianguo Dong of Wuhan Union Hospital Gives Speech Entitled “Clinical Experience with the MoyoAssist® Extracorporeal Ventricular Assist Device”
2023-01-06
Corporate
Highlights|magAssist Invited to Join VBData’s Live Stream on The Future is Now a Reality! Percutaneous Ventricular Assist Devices Fast-tracked for Clinical Application
2022-12-12
Corporate
Suzhou City leaders led a team to observe key projects in Suzhou High-tech Zone and learn more about the development of magAssist
2021-09-06
《
1
2
2/2
Tabs:
pVAD,
cardiogenic shock,
external life support systems,
ECMO devices,
IABP,
Bridge-to-recovery,
cardiogenic shock treatment,
MoyoAssist Extra-VAD,
solid technology of artificial hearts,
Awards,
TOP